BN Business News
Add your company to Business Communicator →

Business · 18/02/2011Updated: 10/17/2026 · 1 min read

FDA Extends Enforcement Discretion Period for Phytosterols and Coronary Heart Disease Health Claim

Summary

The FDA is extending the period for exercising enforcement discretion on the use of the phytosterols and risk of coronary heart disease health claim from 75 days to 89 days, from December 8, 2010, to February 21, 2012.

Original source language: Federal Register — Health and Human ServicesOpen original release →

Explore insights

Business insights →